General Newsroom Hero 1920x480 (4:1)
Our Work

Latham & Watkins Advises The Oncology Institute in Business Combination With DFP Healthcare Acquisitions Corp.

June 29, 2021
A corporate team advised the US market leading provider of value-based oncology care in the transaction.

DFP Healthcare Acquisitions Corp, a special purpose acquisition company sponsored by an affiliate of Deerfield Management Company, L.P. (Deerfield) and Richard Barasch, a veteran healthcare public company executive and investor, announced that it has entered into a definitive agreement for a business combination with The Oncology Institute ( TOI or The Company), the US market leader in providing value-based oncology care. Following the business combination, DFP expects to be renamed The Oncology Institute and will remain listed on the NASDAQ stock market under new ticker symbol “TOI”.

Latham & Watkins LLP represents The Oncology Institute with a corporate team led by Century City partner Steve Stokdyk, Los Angeles partner Brian Duff, Century City partner Brent Epstein, Century City counsel Adam Rachlis, with associates Kenneth Hagan, Grace Garcea, Catherine Shaw, Andrew Turk, and Celia Lown. Advice was also provided on tax matters by Bay Area partner Katharine Moir with associate Alan Kimball; on benefits and compensation matters by Chicago partner Robin Struve with associate Victoria Wolfe; on environmental matters by Los Angeles partner Aron Potash with associate Jen Garlock; on HSR matters by Washington, D.C. partner Jason Cruise and Washington, D.C. counsels Peter Todaro and Joseph Simei; on intellectual property matters by Los Angeles partner Ghaith Mahmood with associate Nathan Wages; on healthcare regulatory matters by Los Angeles counsel Jennifer Yoo with associates Yanyan Zhou and Leia Gu: and on data privacy matters by Bay Area counsel Heather Deixler.